GEN Gen Digital (GEN) Insider Trading, Ownership & Congress Trades
Software & IT · Services-prepackaged software · CIK 0000849399
Congress · 1Form 144 · 5
Funds added, last quarter
399
13F, latest reported quarter
Conversions, 180 days
3
Codes C/M, not in net · $22.0M priced
What the filings say about GEN
Insiders, 180 days
-$18.8M net sold
1 buyer · 3 sellers · 12% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 0 sold
Latest: purchase, 2026-04-14
Planned sales (Form 144), 90 days
$16.4M
5 notices
Gen Digital insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Gen Digital Inc. insiders sold a net $18.8M of stock across 27 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Aug 13, 2025.
- The trade is 3.8% of the 744,262 shares held after it.
- 2 other insiders sold within 30 days.
- 399 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: COO, CLO and Secretary KO BRYAN SEUK sold about $866.5K of GEN under a 10b5-1 plan on Sep 4, 2026; 2 other insiders sold within 30 days and 399 funds added in the latest 13F quarter.Context
- 6 earlier Form 4 trades (code P or S) here by this insider (1 buy, 5 sales), the last on Aug 25, 2026.
- The trade is 6.0% of the 3,332,904 shares held after it.
- 2 other insiders sold within 30 days.
- 399 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Vlcek Ondrej sold about $6.0M of GEN on Aug 27, 2026, the largest insider sale at the company since 2024; 2 other insiders sold within 30 days and 399 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (1 buy, 4 sales), the last on Aug 21, 2026.
- The trade is 4.3% of the 3,532,904 shares held after it.
- 2 other insiders sold within 30 days.
- 399 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Vlcek Ondrej sold about $4.4M of GEN on Aug 25, 2026, the largest insider sale at the company since 2024; 2 other insiders sold within 30 days and 399 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (1 buy, 3 sales), the last on Aug 19, 2026.
- The trade is 1.3% of the 3,685,262 shares held after it.
- 2 other insiders sold within 30 days.
- 399 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Vlcek Ondrej sold about $1.4M of GEN on Aug 21, 2026; 2 other insiders sold within 30 days and 399 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (1 buy, 2 sales), the last on Jun 10, 2026.
- The trade is 2.7% of the 3,732,724 shares held after it.
- 2 other insiders sold within 30 days.
- 399 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Vlcek Ondrej sold about $2.8M of GEN on Aug 19, 2026; 2 other insiders sold within 30 days and 399 funds added in the latest 13F quarter.27 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$18.8M over 180 days
-$16.4M over 90 days
below 76% of Software & IT
Congress
1 member bought in the last year
the lowest in Software & IT
Funds
399 funds bought in last quarter
more than 90% of Software & IT
Revenue
+27.1% year over year
more than 77% of Software & IT
Margin
19.5% net margin
more than 84% of Software & IT
Buybacks
$100.0M repurchased, FY to 2026-07-03
more than 54% of Software & IT
Short interest
7.8% of the float short (float per yahoo 2026-10-26) · 2.2 days to cover · settled 2026-09-30
more than 70% of Software & IT
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch GEN
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-7.1%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns GEN: institutional holders (13F)
13F holdings, latest reported quarter
53,447,955 sh
$1.3B
46,348,313 sh
$1.2B
35,673,604 sh
$887.9M
31,242,349 sh
$777.6M
30,421,259 sh
$757.2M
Congress trades in GEN
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Bought 2026-04-14 · disclosed 24 days later
$1,001 - $15,000
Sold 2025-10-22 · disclosed 23 days later
$1,001 - $15,000
Bought 2025-10-21 · disclosed 288 days later
$1,001 - $15,000
Sold 2025-10-21 · disclosed 288 days later
$1,001 - $15,000
Sold 2025-09-23 · disclosed 17 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
GEN planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
BRYAN KO
Filed 2026-09-04
$885.0K
Vlcek Ondrej
Filed 2026-08-25
$10.4M
Vlcek Ondrej
Filed 2026-08-21
$1.4M
Vlcek Ondrej
Filed 2026-08-19
$2.8M
Witteveen Travis Michael
Filed 2026-08-12
$882.6K
GEN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Global X Cybersecurity ETF
$52.5M position · as of 2026-05-31
4.5%
Amplify Cybersecurity ETF
$95.6M position · as of 2026-06-30
3.7%
DWS CROCI(R) Equity Dividend Fund
$24.8M position · as of 2026-05-31
3.1%
First Trust Horizon Managed Volatility Domestic ETF
$2.2M position · as of 2026-07-31
3.0%
LYRICAL U.S. VALUE EQUITY FUND
$31.2M position · as of 2026-05-31
2.5%
Brown Advisory - Beutel Goodman Large-Cap Value Fund
$19.7M position · as of 2026-06-30
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2022
$25.3M
$5.7M
$9.0M
+8%
+101%
2021
$13.5M
$20.7M
$12.1M
+56%
+110%
2020
$13.8M
$24.2M
$4.0M
+20%
+77%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $18.8M sold by insiders over 180 days, 399 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $16.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
GEN financials
Revenue growth
+27.1%
XBRL, annual
Net margin
19.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$5.1B
four quarters, 2025-07-05 to 2026-07-03
Revenue, TTM GEN
| FY Apr 2026 | $5.0B |
| FY Mar 2025 | $3.9B |
| FY Mar 2024 | $3.8B |
| FY Mar 2023 | $3.3B |
| FY Apr 2022 | $2.8B |
| Jul 2026 | $1.3B |
| Apr 2026 | $1.3B |
| Jan 2026 | $1.2B |
| Oct 2025 | $1.2B |
| Jul 2025 | $1.3B |
| Mar 2025 | $1.0B |
| Dec 2024 | $986.0M |
| Sep 2024 | $974.0M |
At each fiscal year end
Single quarter
Net margin, TTM
+20.7%
net income over revenue, 2025-07-05 to 2026-07-03
Net margin, TTM GEN
| FY Apr 2026 | +19.5% |
| FY Mar 2025 | +16.3% |
| FY Mar 2024 | +15.9% |
| FY Mar 2023 | +40.0% |
| FY Apr 2022 | +29.9% |
| Jul 2026 | +16.1% |
| Apr 2026 | +39.9% |
| Jan 2026 | +15.5% |
| Oct 2025 | +11.0% |
| Jul 2025 | +10.7% |
| Mar 2025 | +14.1% |
| Dec 2024 | +16.1% |
| Sep 2024 | +16.5% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.5B
operating cash flow minus capex, 2025-07-05 to 2026-07-03
Free cash flow, TTM GEN
| FY Apr 2026 | $1.5B |
| FY Mar 2025 | $1.2B |
| FY Mar 2024 | $2.0B |
| FY Mar 2023 | $751.0M |
| FY Apr 2022 | $968.0M |
| Jul 2026 | $430.0M |
| Apr 2026 | $476.0M |
| Jan 2026 | $535.0M |
| Oct 2025 | $107.0M |
| Jul 2025 | $405.0M |
| Mar 2025 | $470.0M |
| Dec 2024 | $318.0M |
| Sep 2024 | $156.0M |
At each fiscal year end
Single quarter
Debt to equity
3.07x
long-term 2026-07-03 plus current 2026-07-03; equity 2026-07-03
Debt to equity GEN
| FY Apr 2026 | 3.14x |
| FY Mar 2025 | 3.64x |
| FY Mar 2024 | 4.02x |
| FY Mar 2023 | 4.54x |
| FY Apr 2022 | n/a |
| Jul 2026 | 3.07x |
| Apr 2026 | 3.14x |
| Jan 2026 | 3.61x |
| Oct 2025 | 3.54x |
| Jul 2025 | 3.75x |
| Mar 2025 | 3.64x |
| Dec 2024 | 3.94x |
| Sep 2024 | 4.06x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.19x
TTM operating cash flow over long-term 2026-07-03 plus current 2026-07-03
Cash flow to debt GEN
| FY Apr 2026 | 0.19x |
| FY Mar 2025 | 0.15x |
| FY Mar 2024 | 0.24x |
| FY Mar 2023 | 0.08x |
| FY Apr 2022 | 0.26x |
| Jul 2026 | 0.19x |
| Apr 2026 | 0.19x |
| Jan 2026 | 0.18x |
| Oct 2025 | 0.15x |
| Jul 2025 | 0.15x |
| Mar 2025 | 0.15x |
| Dec 2024 | 0.25x |
| Sep 2024 | 0.25x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+41.9%
TTM net income over average of 2025-07-04 and 2026-07-03
Return on equity GEN
| FY Apr 2026 | +39.9% |
| FY Mar 2025 | +29.2% |
| FY Mar 2024 | +28.3% |
| FY Mar 2023 | +131.7% |
| FY Apr 2022 | n/a |
| Jul 2026 | +41.9% |
| Apr 2026 | +39.9% |
| Jan 2026 | +26.9% |
| Oct 2025 | +25.0% |
| Jul 2025 | +27.5% |
| Mar 2025 | +29.2% |
| Dec 2024 | +28.0% |
| Sep 2024 | +27.6% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+6.6%
TTM net income over average of 2025-07-04 and 2026-07-03
Return on assets GEN
| FY Apr 2026 | +6.3% |
| FY Mar 2025 | +4.1% |
| FY Mar 2024 | +3.8% |
| FY Mar 2023 | +11.7% |
| FY Apr 2022 | +12.6% |
| Jul 2026 | +6.6% |
| Apr 2026 | +6.3% |
| Jan 2026 | +3.9% |
| Oct 2025 | +3.6% |
| Jul 2025 | +3.8% |
| Mar 2025 | +4.1% |
| Dec 2024 | +4.0% |
| Sep 2024 | +3.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+14.9%
operating income after a 31.4% effective tax rate, over long-term 2026-07-03 plus current 2026-07-03 plus average of 2025-07-04 and 2026-07-03 minus cash
Return on invested capital GEN
| FY Apr 2026 | +14.1% |
| FY Mar 2025 | +10.5% |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Apr 2022 | +40.1% |
| Jul 2026 | +14.9% |
| Apr 2026 | +14.1% |
| Jan 2026 | +9.5% |
| Oct 2025 | +9.2% |
| Jul 2025 | +9.2% |
| Mar 2025 | +10.5% |
| Dec 2024 | +10.5% |
| Sep 2024 | +10.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+16.0%
operating income (EBIT proxy) over average of 2025-07-04 and 2026-07-03 minus current liabilities
Return on capital employed GEN
| FY Apr 2026 | +16.6% |
| FY Mar 2025 | +12.5% |
| FY Mar 2024 | +8.5% |
| FY Mar 2023 | +14.2% |
| FY Apr 2022 | +24.8% |
| Jul 2026 | +16.0% |
| Apr 2026 | +16.6% |
| Jan 2026 | +14.0% |
| Oct 2025 | +13.3% |
| Jul 2025 | +13.0% |
| Mar 2025 | +12.5% |
| Dec 2024 | +12.6% |
| Sep 2024 | +12.1% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
14.55x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-05 to 2026-07-03
P/E, trailing GEN
| FY Apr 2026 | 12.03x |
| FY Mar 2025 | 25.41x |
| FY Mar 2024 | 23.58x |
| FY Mar 2023 | 8.02x |
| FY Apr 2022 | 19.11x |
| Jul 2026 | 15.60x |
| Apr 2026 | 12.03x |
| Jan 2026 | 26.88x |
| Oct 2025 | 30.24x |
| Jul 2025 | 31.43x |
| Mar 2025 | 25.41x |
| Dec 2024 | 27.11x |
| Sep 2024 | 28.03x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$22.0B
market value at close 2026-10-23 on 2026-08-04 shares, plus long-term 2026-07-03 plus current 2026-07-03, minus cash 2025-03-28
Enterprise value GEN
| FY Apr 2026 | $18.6B |
| FY Mar 2025 | $23.5B |
| FY Mar 2024 | $22.0B |
| FY Mar 2023 | $20.0B |
| FY Apr 2022 | $17.5B |
| Jul 2026 | $23.2B |
| Apr 2026 | $18.6B |
| Jan 2026 | $23.5B |
| Oct 2025 | $24.8B |
| Jul 2025 | $26.8B |
| Mar 2025 | $23.5B |
| Dec 2024 | $24.6B |
| Sep 2024 | $24.7B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+10.4%
TTM free cash flow over market value at close 2026-10-23
FCF yield GEN
| FY Apr 2026 | +13.3% |
| FY Mar 2025 | +7.4% |
| FY Mar 2024 | +14.3% |
| FY Mar 2023 | +6.8% |
| FY Apr 2022 | +6.2% |
| Jul 2026 | +9.6% |
| Apr 2026 | +13.3% |
| Jan 2026 | +9.4% |
| Oct 2025 | +7.6% |
| Jul 2025 | +7.1% |
| Mar 2025 | +7.4% |
| Dec 2024 | +12.5% |
| Sep 2024 | +12.5% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.19x
P/E over trailing EPS growth of 76%: four quarters to 2026-07-03 against the four to 2025-07-04
PEG, trailing GEN
| FY Apr 2026 | 0.24x |
| FY Mar 2025 | 2.68x |
| FY Mar 2024 | n/a |
| FY Mar 2023 | 0.15x |
| FY Apr 2022 | 0.36x |
| Jul 2026 | 0.20x |
| Apr 2026 | 0.24x |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | 14.93x |
| Mar 2025 | 2.68x |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-04 | 2025-03 | 2024-03 | 2023-03 | |
|---|---|---|---|---|
| Revenue | $5.0B | $3.9B | $3.8B | $3.3B |
| Gross profit | $3.9B | $3.2B | $3.1B | $2.7B |
| Operating income | $2.1B | $1.6B | $1.1B | $1.2B |
| Net income | $973.0M | $643.0M | $607.0M | $1.3B |
| EPS (diluted) | 1.57 | 1.03 | 0.95 | 2.14 |
| Operating cash flow | $1.5B | $1.2B | $2.1B | $757.0M |
| Cash | n/a | $1.0B | $846.0M | $750.0M |
| Long-term debt | $8.0B | $8.0B | $8.4B | $9.5B |
| Buybacks | $634.0M | $272.0M | $441.0M | $904.0M |
| Dividends paid | $312.0M | $313.0M | $323.0M | $314.0M |
SEC XBRL, fiscal years, as known on 2026-10-27
GEN Stock Sonar score 6/7 axes
Find similar shapesCompareGEN ranks highest on profitability (75th percentile) and institutional and government (60th), and lowest on financial health (24th), among Software & IT peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
GEN filings, in plain words
Are Gen Digital insiders buying or selling GEN?
In the 180 days to 2026-10-27, Gen Digital insiders were net sellers, a net $18.8M: $81.2K of purchases and $18.8M of sales reported on Form 4, by 1 buyer and 3 sellers.
Have members of Congress traded GEN?
Yes. In the year to 2026-10-27, 1 House member disclosed buying GEN and 0 House members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-04-14.
Are there planned insider sales of GEN?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $16.4M of stock; the latest, by BRYAN KO, was filed 2026-09-04.
Read the full summary
In the 180 days to 2026-10-27, Gen Digital insiders were net sellers of GEN, a net $18.8M across purchases and sales reported on Form 4 by 1 buyer and 3 sellers. Sales outweighed purchases more than tenfold by value. 12% of the 8 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-27, 1 member of Congress disclosed buying GEN and 0 members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-04-14. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $16.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
